OPHLY: second_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/cae2e26a-335d-4c38-8012-bfacced1ddfb/","filing_uuid":"cae2e26a-335d-4c38-8012-bfacced1ddfb","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cae2e26a-335d-4c38-8012-bfacced1ddfb/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"CHRISTINE M. SCHAUT","dt_posted":"2026-07-20T09:30:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2101 L Street, NW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":16896,"url":"https://lda.gov/api/v1/registrants/16896/","house_registrant_id":31595,"name":"GREENBERG TRAURIG, LLP","description":"Law firm","address_1":"2101 L Street, NW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTINE M. SCHAUT","contact_telephone":"+1 202-331-3100","dt_updated":"2026-07-20T10:02:59.584284-04:00"},"client":{"id":52685,"url":"https://lda.gov/api/v1/clients/52685/","client_id":52685,"name":"ONO PHARMACEUTICAL CO., LTD (FORMERLY ONO PHARMA USA)","general_description":"Pharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-08-19"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitor administrative and legislative action affecting FDA drug approvals","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60601,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"MANGAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62724,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":"F.","last_name":"BASS","suffix":null,"suffix_display":null},"covered_position":"U.S. Congressman (97 - 07) & (11 - 13)","new":false},{"lobbyist":{"id":73022,"prefix":null,"prefix_display":null,"first_name":"RODNEY","nickname":null,"middle_name":null,"last_name":"FRELINGHUYSEN","suffix":null,"suffix_display":null},"covered_position":"U.S. Congressman (1995 - 2019)","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}